CIK: 1400901 - Address: C/o Rapt Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, CA 94080
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/22/23 14:31
12/21/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-5421.680-3-1415D
11/29/23 14:29
11/28/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-2113.720-2-818D
10/4/23 18:29
10/3/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-3915.770-3-1219D
8/22/23 12:19
8/18/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-4718.920-3-1121D
8/3/23 14:34
7/28/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d612.0000224D
6/27/23 12:14
6/23/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d1112.0001423D
4/20/23 14:17
4/19/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-9418.880-5-1921D
4/14/23 18:25
4/13/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d612.0000222D
3/13/23 14:21
3/7/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-14829.620-5-1626D
3/6/23 14:25
3/3/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d612.0000231D
1/26/23 14:29
1/24/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-15030.000-5-1430D
1/20/23 18:33
1/19/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-12825.560-5-1235D
1/17/23 16:10
1/12/23
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d239.5502640D
12/30/22 18:57
12/29/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-9018.030-5-1238D
11/29/22 14:49
11/28/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-8917.870-5-1043D
11/3/22 18:44
11/2/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-11222.320-5-948D
10/14/22 14:41
10/13/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-4321.520-2-453D
10/4/22 12:47
10/3/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d89.5501155D
9/6/22 19:55
9/1/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d89.5501254D
8/31/22 14:33
8/30/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-7028.130-3-553D
8/15/22 17:48
8/12/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d89.5501156D
7/13/22 17:33
7/11/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS.d-4019.950-2-455D
7/13/22 17:33
7/11/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d239.5502555D
4/12/22 19:04
4/11/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d1112.0001254D
4/7/22 15:25
4/6/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeS-6922.960-3-553D
4/4/22 19:29
4/4/22
RAPTRapt Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHo WilliamCAOChief MeM.d46.3001156D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact